Anthony Virtue

2.0k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Anthony Virtue is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Anthony Virtue has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Anthony Virtue's work include MicroRNA in disease regulation (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Anthony Virtue is often cited by papers focused on MicroRNA in disease regulation (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Anthony Virtue collaborates with scholars based in United States, Japan and France. Anthony Virtue's co-authors include Jietang Mai, Xiaofeng Yang, Jerry Shen, Hong Wang, Xiaofeng Yang, Xinyuan Li, Xiaohua Jiang, Ying Yin, Xiaojin Sha and Hong Wang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Anthony Virtue

17 papers receiving 1.3k citations

Hit Papers

The gut microbiota regulates white adipose tissue inflamm... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Virtue United States 12 631 533 235 208 198 17 1.3k
Tommaso Scolaro Belgium 3 560 0.9× 791 1.5× 140 0.6× 191 0.9× 165 0.8× 3 1.4k
Juliana P. Vago Brazil 24 751 1.2× 792 1.5× 173 0.7× 164 0.8× 171 0.9× 48 1.8k
Marten A. Hoeksema Netherlands 21 779 1.2× 1.0k 2.0× 173 0.7× 311 1.5× 192 1.0× 39 1.8k
Kenneth Hsu Australia 21 880 1.4× 596 1.1× 190 0.8× 178 0.9× 181 0.9× 32 1.4k
Jonas Byström United Kingdom 27 479 0.8× 805 1.5× 356 1.5× 203 1.0× 116 0.6× 44 2.0k
Shihab Kochumon Kuwait 22 378 0.6× 454 0.9× 232 1.0× 395 1.9× 128 0.6× 48 1.2k
Reeby Thomas Kuwait 22 386 0.6× 397 0.7× 281 1.2× 422 2.0× 112 0.6× 39 1.2k
Anastasia Sobolewski United Kingdom 14 472 0.7× 439 0.8× 179 0.8× 110 0.5× 375 1.9× 21 1.5k
Candice Johnson United States 17 492 0.8× 409 0.8× 124 0.5× 311 1.5× 143 0.7× 32 1.2k
Gantsetseg Tumurkhuu Japan 20 651 1.0× 590 1.1× 94 0.4× 140 0.7× 144 0.7× 51 1.3k

Countries citing papers authored by Anthony Virtue

Since Specialization
Citations

This map shows the geographic impact of Anthony Virtue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Virtue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Virtue more than expected).

Fields of papers citing papers by Anthony Virtue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Virtue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Virtue. The network helps show where Anthony Virtue may publish in the future.

Co-authorship network of co-authors of Anthony Virtue

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Virtue. A scholar is included among the top collaborators of Anthony Virtue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Virtue. Anthony Virtue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Virtue, Anthony, Sam J. McCright, Jasmine M. Wright, et al.. (2019). The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Science Translational Medicine. 11(496). 243 indexed citations breakdown →
2.
Lenhard, Stephen C., Anthony Virtue, William Fieles, et al.. (2019). In Vivo Imaging of Small Molecular Weight Peptides for Targeted Renal Drug Delivery: A Study in Normal and Polycystic Kidney Diseased Mice. Journal of Pharmacology and Experimental Therapeutics. 370(3). 786–795. 9 indexed citations
3.
Johnson, Candice, Charles Drummer, Anthony Virtue, et al.. (2018). Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. Frontiers in Physiology. 9. 1297–1297. 38 indexed citations
4.
Virtue, Anthony, Candice Johnson, Jahaira Lopez‐Pastrana, et al.. (2016). MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease. Journal of Biological Chemistry. 292(4). 1267–1287. 81 indexed citations
5.
Mai, Jietang, Gayani Nanayakkara, Jahaira Lopez‐Pastrana, et al.. (2016). Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway. Journal of Biological Chemistry. 291(10). 4939–4954. 73 indexed citations
6.
Mai, Jietang, Gayani Nanayakkara, Jahaira Lopez‐Pastrana, et al.. (2016). Interlukin‐17A Promotes Aortic Endothelial Activation Via Transcriptionally and Post Transcriptionally Activating p38 MAPK Pathway. The FASEB Journal. 30(S1). 2 indexed citations
7.
Yin, Ying, Xinyuan Li, Xiaojin Sha, et al.. (2015). Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 Pathway. Arteriosclerosis Thrombosis and Vascular Biology. 35(4). 804–816. 168 indexed citations
8.
Mai, Jietang, Anthony Virtue, Jerry Shen, Hong Wang, & Xiaofeng Yang. (2013). An evolving new paradigm: endothelial cells – conditional innate immune cells. Journal of Hematology & Oncology. 6(1). 61–61. 332 indexed citations
9.
Du, Fuyong, Anthony Virtue, Hong Wang, & Xiaofeng Yang. (2013). Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomarker Research. 1(1). 17–17. 53 indexed citations
10.
Huang, Xiao, Xinyuan Li, Anthony Virtue, et al.. (2013). Identification of Novel Pretranslational Regulatory Mechanisms for NF-κB Activation. Journal of Biological Chemistry. 288(22). 15628–15640. 17 indexed citations
11.
Virtue, Anthony, Hong Wang, & Xiaofeng Yang. (2013). MicroRNA‐155 plays an important role in endothelial cell activation. The FASEB Journal. 27(S1). 1 indexed citations
12.
Li, Xinyuan, Jietang Mai, Anthony Virtue, et al.. (2012). IL-35 Is a Novel Responsive Anti-inflammatory Cytokine — A New System of Categorizing Anti-inflammatory Cytokines. PLoS ONE. 7(3). e33628–e33628. 202 indexed citations
13.
Yang, Xiaofeng, Xinyuan Li, Jietang Mai, et al.. (2012). IL-35 Is a Novel Responsive Anti-Inflammatory Cytokine - A New System of Categorizing Anti-Inflammatory Cytokines. Blood. 120(21). 5197–5197. 1 indexed citations
14.
Virtue, Anthony, Luqiao Wang, & Xiaofeng Yang. (2012). MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling. Journal of Hematology & Oncology. 5(1). 66–66. 62 indexed citations
15.
Li, Xinyuan, Jietang Mai, Anthony Virtue, Hong Wang, & Xiaofeng Yang. (2012). IL‐35 is a Novel Responsive Anti‐inflammatory Cytokine ‐ A New System of Categorizing Anti‐inflammatory Cytokines. The FASEB Journal. 26(S1). 27 indexed citations
16.
Virtue, Anthony. (2011). Structural evidence of anti-atherogenic microRNAs. Frontiers in bioscience. 16(1). 3133–3133. 14 indexed citations
17.
Jan, Michael, Anthony Virtue, Jingshan Liu, et al.. (2011). The Role of Immunogenicity in Cardiovascular Disease.. PubMed. 3(1). 1–29. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026